PELAREOREP
UNII S9J80L3D1U

Substance Identification & Data

This profile provides standardized clinical and technical data for Pelareorep, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9J80L3D1U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1383626-61-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
S9J80L3D1U
CAS Registry Number
1383626-61-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PELAREOREP
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
AB-12
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pelareorep. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PELAREOREP

Common Names & Synonyms

MAMMALIAN ORTHOREOVIRUS 3 STRAIN DEARING
MAMMALIAN ORTHOREOVIRUS 3-DEARING
PELAREOREP [USAN]
PELAREOREP [WHO-DD]
REOVIRUS (TYPE 3 / STRAIN DEARING)
REOVIRUS 3 (STRAIN DEARING)
REOVIRUS TYPE 3 (STRAIN DEARING)
REOVIRUS TYPE 3 (STRAIN DEARING) (T3D) (MAMMALIAN ORTHOREOVIRUS 3)
REOVIRUS TYPE 3 DEARING ONCOLYTIC VIRUS WITHOUT TRANSGENES
T3D

Brand / Trade Names

REOLYSIN

Technical Codes

PO BB0209
PO-BB0209
PO-BB-0209